Safety Assessment of Glucose-Lowering Drugs and Importance of Structured Education during Ramadan: A Systematic Review and Meta-Analysis.
Rashmi ShijuAyesha AkhilSmitha ThankachanJaakko TuomilehtoMonira Al AroujAbdullah BennakhiPublished in: Journal of diabetes research (2022)
The results of our systematic review show that structured education and counselling by healthcare professionals can be an effective tool in preventing complications associated with fasting during Ramadan in people with T2DM. Additionally, the safest class of oral glucose-lowering drugs preferred during Ramadan fasting in T2DM patients is DPP-4 inhibitors.
Keyphrases
- blood glucose
- systematic review
- end stage renal disease
- healthcare
- newly diagnosed
- chronic kidney disease
- glycemic control
- insulin resistance
- quality improvement
- prognostic factors
- meta analyses
- type diabetes
- risk factors
- blood pressure
- metabolic syndrome
- hepatitis c virus
- human immunodeficiency virus
- hiv infected
- hiv testing